23 May 2013
Keywords: aphton, opts, against, renewal, licensing, deal, aventis
Article | 28 April 2003
Miami, USA-based Aphton says that, following its decision to raisesome $20 million in additional financing via the sale of notes and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 April 2003
22 May 2013
© 2013 thepharmaletter.com